Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic
Transfusion · 2024
DOI: 10.1111/trf.17851 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transfusion, 2024. Verfasst von Galen Conti und 10 weiteren Autor:innen. Beteiligte Einrichtung: American Red Cross, Rockville, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19, Blood Donors, SARS-CoV-2. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: U.S. Food and Drug Administration, Office of the Assistant Secretary for Health, NIH HHS.
Abstract (Originalsprache)
Background
The COVID‐19 pandemic impacted the US blood supply. We compared blood donor demography and infectious disease prevalence before and during the pandemic using a large multicenter database.
Methods
Data were categorized as “Before COVID‐19” (March 2018–February 2020) or “During COVID‐19” (March 2020–February 2022). Donor demographics, donation frequency, and infectious marker prevalence of HIV, HBV, and HCV were compared for the two time periods. The odds of a donor testing positive for these infections among the two time periods were calculated using multivariable logistic regression.
Results
Our study assessed a total of 26,672,213 donations including 13,430,380 before and 13,241,833 during COVID‐19. There were significantly more donations from donors who were female, aged 40 and older, white, and repeat, during COVID‐19. Donation frequency comparison quantified the increase in donations from donors who were white, female, older, and repeat during the pandemic. The prevalence of HIV and HCV decreased significantly during COVID‐19 compared to before, but not for HBV. For HIV, the adjusted odds of infection during the pandemic did not differ but for HBV, the odds were significantly more likely during the pandemic and were significantly lower for HCV.
Discussion
Demographics and infectious disease marker prevalence changed during the COVID‐19 pandemic in the United States. Prevalence of each infection in the donor population will continue to be monitored to determine if changes were specific to the pandemic period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- American Red Cross, Rockville, Maryland, USA.
- New York Blood Center Enterprises, New York, New York, USA.
- Vitalant Research Institute, San Francisco, California, USA.
- Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
- OneBlood, St. Petersburg, Florida, USA.
- US Food and Drug Administration, Silver Spring, Maryland, USA.
ORCID-Profile: Galen Conti, Brian Custer, Roberta Bruhn, Barbee I Whitaker, Susan L Stramer
Förderung
- U.S. Food and Drug Administration
- Office of the Assistant Secretary for Health
- NIH HHS
- National Institutes of Health
Zitieren
APA
Conti, G., Notari, E. P., Dodd, R. Y., Kessler, D., Custer, B., Bruhn, R., Reik, R., Yang, H., Whitaker, B. I., Stramer, S. L., & U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS) (2024). Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic. Transfusion. https://doi.org/10.1111/trf.17851
Vancouver
Conti G, Notari EP, Dodd RY, Kessler D, Custer B, Bruhn R, et al. Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic. Transfusion. 2024. doi:10.1111/trf.17851
BibTeX
@article{Conti2024,
author = {Conti, Galen and Notari, Edward P and Dodd, Roger Y and Kessler, Debra and Custer, Brian and Bruhn, Roberta and Reik, Rita and Yang, Hong and Whitaker, Barbee I and Stramer, Susan L and U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS), U.S. Transfusion‐Transmissible Infections Monitoring System (TTIMS)},
title = {Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID ‐19 pandemic},
journal = {Transfusion},
year = {2024},
doi = {10.1111/trf.17851}
}
EUVIMED